Better know hyaluronic acid

An interview with Hyuntae Jung, Life Sciences R&D of LG Chem Hyaluronic acid is everywhere you look (literally in your eyes and your skin), and with its exponential growth as a component in treatments from cosmetics to oncological drug delivery systems, we focus on issues surrounding its clinical application for the treatment of osteoarthritis. Dr. […]

If it’s not broken don’t fix it: Top bone substitute material for effective antibiotic and bone defect treatment outcomes

A Q&A with Professor Dr. Christian Heiss Professor Dr. h.c. Christian Heiss, head of the Department of Trauma, Hand and Reconstructive Surgery at the University Hospital of Giessen, Germany gave information to EFORT about the advantages and disadvantages of a synthetic, biodegradable and osteoconductive bone substitute material known as PerOssal® – a degradable composite of […]

In Memoriam Professor Jacques Duparc – EFORT Founding Father

Prof. Pierre Hoffmeyer, EFORT Past President:“Jacques Duparc was the last of the great French chiefs of orthopaedics. You never said no to Duparc. When he was Editor in chief of the SOFCOT Instructional Lectures, he was relentless, and he personally chased tardy writers and if things did not go well, he would call their boss.” […]

AIOT Joint Statement Against War

AIOT Joint Statement Against War | 04 March 2022 The situation that creates consequences that orthopaedic surgeons have the most difficulty dealing with in their professional lives is war. APOA, EFORT, PAOA, SICOT and SLAOT are adamantly against war. As AIOT, we express our belief in the right to sovereignty of every nation, and that […]

Message of support for Ukraine

EFORT Head Office | Rolle, Switzerland, 03 March 2022 It is with great sadness and deep concern that the European Federation of National Associations of Orthopaedics and Traumatology (EFORT), learns of the rapidly unfolding situation and humanitarian crisis in Ukraine. While we remain an apolitical federation of the national societies of orthopaedics and traumatology in […]

EFORT Statement on Cobalt in Orthopaedic implants

Update from the earlier Joint Statement of EFORT and MedTech Europe’s Orthopaedic Sector Group from the 14 August 2018. Rolle, Switzerland, 24 August 2021 The EU Commission will, after receiving guidance from the ECHA on October 1 2021, raise the concern level for Cobalt contained in medical devices. The latter has been discussed for a […]

EFORT and Orthofix to launch new digital educational offering

The pandemic has taught us to adapt and make our organisation agile. It is our first priority to preserve everyone’s health and deliver Education & Training in a safe environment. As a consequence, collaborative schemes with our industry partners should reflect an unexpected positive impact of this pandemic. “We are working on a richer offer […]

EFORT CONGRESS 2021: OFFICIAL STATEMENT

Rolle | Switzerland | 20 January 2021 | COVID-19: EFORT’s OFFICIAL STATEMENT FOR VIENNA 2021 Dear EFORT Community, Strong from the experience of our first virtual congress last year, Vienna should have been our congress venue this year and we would have been prepared and delighted to welcome you this summer in Austria for the […]

EFORT Orthopaedics Today Europe: Volume 23 | Issue no. 08 | November 2020

By EFORT Head Office | The November 2020 issue of EFORT’s online newspaper Orthopaedics Today Europe (OTE) is now available! EFORT’s official newspaper, ORTHOPAEDICS TODAY EUROPE (OTE) is a digital-only newspaper, all HTML, mobile-optimized format, with new monthly publications for our global readership. Each issue provides high level editorial features and clinical news content as […]

EFORT Orthopaedics Today Europe: Volume 23 | Issue no. 07 | October 2020

By EFORT Head Office | The October 2020 issue of EFORT’s online newspaper Orthopaedics Today Europe (OTE) is now available! EFORT’s official newspaper, ORTHOPAEDICS TODAY EUROPE (OTE) is a digital-only newspaper, all HTML, mobile-optimized format, with new monthly publications for our global readership. Each issue provides high level editorial features and clinical news content as […]

Back to top